Dr. Lung David Christopher - Clinical Microbiology and Infection
Specialist in Clinical Microbiology and Infection
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical Microbiology and InfectionBachelor of Medicine and Bachelor of Surgery (MBBS) · The Hong Kong College of Pathologists · Medical degree 2004
- InsuranceBeing compiled｜See details
About
Dr. Lung David Christopher is a registered Clinical Microbiology and Infection specialist in Hong Kong.
Education
Specialist in Clinical Microbiology and Infection
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2004
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lung David Christopher? Claim page and update insurance →
FAQ
Is Dr. Lung David Christopher any good?
Dr. Lung David Christopher is a registered Clinical Microbiology and Infection specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Lung David Christopher do?
Dr. Lung David Christopher practises in Clinical Microbiology and Infection.
Are you Dr. Lung David Christopher? Claim this page to update and manage.
ClaimResearch and publications
40 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Universal decolonization for methicillin-resistant <i>Staphylococcus aureus</i> and carbapenem-resistant <i>Acinetobacter</i> in elderly homes: A large cohort of over 16,000 residents in Hong Kong.Public health in practice (Oxford, England) · 2026
- Epidemiology and clinical characteristics of rat hepatitis E virus infection in humans.The Journal of infection · 2026
- Long-range air dispersal as an important source of environmental contamination in <i>Candida auris</i> clustering: possible infection control implication.Infection control and hospital epidemiology · 2026
- Macrolide-Resistant <i>Bordetella pertussis</i> in Hong Kong: Evidence for Post-COVID-19 Emergence of <i>ptxP3</i>-Lineage MT28 Clone from a Hospital-Based Surveillance Study.Microorganisms · 2025
- Outbreak of melioidosis in a highly urbanized area.Emerging microbes & infections · 2025
- Post-COVID-19 Pandemic Rebound of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Infection: A Descriptive Study.Antibiotics (Basel, Switzerland) · 2024
- Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide Study.Vaccines · 2024
- Co-existence of airborne SARS-CoV-2 infection and non-infection in three connected zones of a restaurant.Journal of hazardous materials · 2024
- Invasive Fungal Infections in the Paediatric Intensive Care Unit: A Hong Kong Study.Current pediatric reviews · 2024
- Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters.Emerging microbes & infections · 2023
- Air dispersal of respiratory viruses other than severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and the implication on hospital infection control.Infection control and hospital epidemiology · 2023
- Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer